Concepedia

Clement Lai

CL

6

Publications

2.2K

Citations

6

H-Index

2001

Active since

Affiliations

University of Bristol(Current)

Oxford University Clinical Research Unit

Oxford University Hospitals NHS Trust

NIHR Oxford Musculoskeletal Biomedical Research Centre

Lancaster University

Clement Lai is an author at University of Bristol specializing in medicine, covid-19, and clinical trials.

Top concepts

MedicineCovid-19ImmunologyAntibioticsAutoimmunityInflammationClinical TrialsGastroenterologyHospital MedicineInfection Control

Publications per year

2001–2023

6

Publications

6

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease

F. Gordon, Clement Lai, Mark I. Hamilton et al. · Gastroenterology · 2001 · 311 citations · Full text

Inflammation, Randomized Placebo-controlled Trial, Immunology +7

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Rows per page

1–5 of 6